Galt current stock price

View the latest Galectin Therapeutics Inc. (GALT) stock price, news, historical Galectin Therapeutics' President and CEO Dr. Harold Shlevin to Present at the 

Nov 08, 2019 · GALT, Galectin Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Galectin Therapeutics Stock Quote: GALT Stock News, Quotes, Analysis | Investors.com Stock Futures Premarket Data: Dow, S&P, NASDAQ - CNBC Where the stock market will trade today based on Dow Jones Industrial Average, S&P 500 and Nasdaq-100 futures and implied open premarket values. Commodities, currencies and global indexes also shown. Stock Summary - TD Ameritrade Nov 06, 2019 · GAAP P/E is a relative valuation measure used to determine if a stock is expensive in relation to its peers. It is calculated by dividing the current stock price by the sum of the Diluted Earnings Per Share from continuing operations BEFORE Extraordinary Items and Accounting Changes over the last reported 12 months. GALT Historical Stock Prices

View a financial market summary for GALT including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to GALT (Galectin Therapeutics Inc.) stock.

Get breaking news and analysis on Galectin Therapeutics, Inc. (GALT) stock, price quote and chart, trading and investing tools. Galectin holders file to offer up to 1.7M shares. SA News•Aug. Galectin sets lower price in rights offering. The Galectin Therapeutics 52-week high stock price is 5.00, which is 190.7% above the current share price. The Galectin Therapeutics 52-week low stock price  Company Name: Galectin Therapeutics Inc., Stock Symbol: GALT, Industry: life- threatening consequences to patients, and those where current treatment  Simply Wall St News. 5 hours ago | Simply Wall St. Have Insiders Been Buying Galectin Therapeutics, Inc. (NASDAQ:GALT) Shares? 1 month ago | Simply Wall   GALT stock rating and analysis - Galectin Therapeutics : a summary of key financial strength Current, Vs Industry, Vs History Price-to-Tangible-Book, 1.79. Stockopedia rates Galectin Therapeutics Inc as a Speculative Style Neutral . Click to view NAQ:GALT's StockReport. Diluted Weighted Average Shares. m. Diluted Shares Outstanding: 25.9 Million. Current P/E: seen from Figure 2, GALT's stock price does not show any correlation with either the NASDAQ. ( CMMP) 

Galectin Therapeutics Inc. Stock Price (GALT) | Barron's

GALT stock quote, chart and news. Get Galectin Therapeutics, Inc.'s stock price today. Galectin Therapeutics Inc Historical Data - GALT | ADVFN Oct 24, 2019 · Free real-time prices, trades, and chat. Galectin Therapeutics (GALT) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. GALT - Galectin Therapeutic News - Barchart.com Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

GALT - Galectin Therapeutic News - Barchart.com

New York Stock Exchange : A-Z Company Listing NYSE - New York Stock Exchange Stock Prices & Quotes, Market Data & A to Z Company Listings. Free Real-time News Alerts: Tell us which stocks you're watching and we'll send you the latest news as Galectin Therapeutics Stock Quote: GALT Stock News, Quotes ... Nov 08, 2019 · GALT, Galectin Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Galectin Therapeutics Stock Quote: GALT Stock News, Quotes, Analysis | Investors.com

Stock analysis for Galectin Therapeutics Inc (GALT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Galectin Therapeutics (GALT) today and set a price target of $4.[] Apr. 3, 2020 at 7:04 a.m. ET on SmarterAnalyst More COVID-19 GALT | Galectin Therapeutics Inc. Stock Price & News - WSJ

Nov 06, 2019 · GAAP P/E is a relative valuation measure used to determine if a stock is expensive in relation to its peers. It is calculated by dividing the current stock price by the sum of the Diluted Earnings Per Share from continuing operations BEFORE Extraordinary Items and Accounting Changes over the last reported 12 months. GALT Historical Stock Prices Galectin Therapeutics (GALT) has the following price history information. Looking back at GALT historical stock prices for the last five trading days, on March 09, 2020, GALT opened at $2.17, traded as high as $2.27 and as low as $2.03, and closed at $2.06. Trading volume was a total of 346.30K shares. Galectin Therapeutics Inc., GALT Advanced Chart - (NAS ... GALT - Galectin Therapeutics Inc. Advanced Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Stock Market Data - Dow Jones, Nasdaq, S&P 500 - CNNMoney